Fifth Third Wealth Advisors LLC Grows Stock Holdings in Colgate-Palmolive (NYSE:CL)

Fifth Third Wealth Advisors LLC grew its stake in shares of Colgate-Palmolive (NYSE:CL) by 13.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 10,767 shares of the company’s stock after acquiring an additional 1,272 shares during the period. Fifth Third Wealth Advisors LLC’s holdings in Colgate-Palmolive were worth $979,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Oak Thistle LLC increased its position in shares of Colgate-Palmolive by 169.1% during the fourth quarter. Oak Thistle LLC now owns 17,284 shares of the company’s stock valued at $1,571,000 after buying an additional 10,861 shares during the period. SeaCrest Wealth Management LLC increased its holdings in Colgate-Palmolive by 2.1% during the 4th quarter. SeaCrest Wealth Management LLC now owns 7,415 shares of the company’s stock worth $674,000 after acquiring an additional 154 shares during the period. Sovereign Financial Group Inc. lifted its stake in Colgate-Palmolive by 3.6% in the 4th quarter. Sovereign Financial Group Inc. now owns 4,215 shares of the company’s stock worth $383,000 after purchasing an additional 146 shares in the last quarter. Quantum Financial Advisors LLC boosted its holdings in Colgate-Palmolive by 6.9% in the 4th quarter. Quantum Financial Advisors LLC now owns 2,526 shares of the company’s stock valued at $230,000 after purchasing an additional 163 shares during the period. Finally, Rosenberg Matthew Hamilton grew its position in shares of Colgate-Palmolive by 95.1% during the 4th quarter. Rosenberg Matthew Hamilton now owns 1,725 shares of the company’s stock valued at $157,000 after purchasing an additional 841 shares in the last quarter. 80.41% of the stock is owned by institutional investors.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.37% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $87.90 on Thursday. The firm has a market cap of $71.82 billion, a PE ratio of 25.19, a price-to-earnings-growth ratio of 3.31 and a beta of 0.44. The company’s fifty day simple moving average is $92.36 and its two-hundred day simple moving average is $97.92. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be issued a dividend of $0.50 per share. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a yield of 2.28%. Colgate-Palmolive’s dividend payout ratio is presently 57.31%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on CL shares. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus downgraded Colgate-Palmolive from a “buy” rating to a “hold” rating and dropped their price target for the company from $105.00 to $101.00 in a research report on Monday, October 28th. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research report on Tuesday, January 7th. Piper Sandler dropped their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Finally, StockNews.com lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a report on Thursday, January 9th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $103.63.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.